Healthcare provider profile · identity verified

Kaitlyn Newbrough

Nurse Practitioner · CLEVELAND, OH · NPI 1659824829

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	853	254
Lisinopril	Lisinopril	506	142
Amlodipine Besylate	Amlodipine Besylate	478	130
Omeprazole	Omeprazole	344	109
Sertraline Hcl	Sertraline Hcl	315	81
Gabapentin	Gabapentin	312	78
Metoprolol Succinate	Metoprolol Succinate	281	80
Levothyroxine Sodium	Levothyroxine Sodium	278	86
Losartan Potassium	Losartan Potassium	240	79
Albuterol Sulfate Hfa	Albuterol Sulfate	236	70
Furosemide	Furosemide	194	52
Trazodone Hcl	Trazodone Hcl	188	57
Rosuvastatin Calcium	Rosuvastatin Calcium	185	57
Hydrochlorothiazide	Hydrochlorothiazide	144	40
Metformin Hcl	Metformin Hcl	139	51
Fluticasone Propionate	Fluticasone Propionate	138	51
Metoprolol Tartrate	Metoprolol Tartrate	135	39
Simvastatin	Simvastatin	129	40
Tamsulosin Hcl	Tamsulosin Hcl	120	32
Xarelto	Rivaroxaban	111	30
Allopurinol	Allopurinol	104	26
Pravastatin Sodium	Pravastatin Sodium	103	24
Metformin Hcl Er	Metformin Hcl	97	33
Famotidine	Famotidine	95	26
Tramadol Hcl	Tramadol Hcl	95	22
Triamcinolone Acetonide	Triamcinolone Acetonide	95	38
Alendronate Sodium	Alendronate Sodium	93	27
Glipizide Er	Glipizide	92	26
Eliquis	Apixaban	91	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	88	29
Clopidogrel	Clopidogrel Bisulfate	79	24
Lidocaine	Lidocaine	74	15
Pantoprazole Sodium	Pantoprazole Sodium	74	19
Mirtazapine	Mirtazapine	72	17
Tradjenta	Linagliptin	67	19
Atenolol	Atenolol	63	16
Montelukast Sodium	Montelukast Sodium	62	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	62	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	61	22
Ozempic	Semaglutide	61	16
Carvedilol	Carvedilol	60	17
Fluoxetine Hcl	Fluoxetine Hcl	56	20
Spironolactone	Spironolactone	56	17
Citalopram Hbr	Citalopram Hydrobromide	54	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	16
Hydralazine Hcl	Hydralazine Hcl	53	11
Finasteride	Finasteride	52	12
Nystatin	Nystatin	52	22
Potassium Chloride	Potassium Chloride	52	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	52	suppressed
Ezetimibe	Ezetimibe	49	11
Chlorthalidone	Chlorthalidone	45	12
Doxazosin Mesylate	Doxazosin Mesylate	44	11
Trulicity	Dulaglutide	44	11
Duloxetine Hcl	Duloxetine Hcl	42	14
Jardiance	Empagliflozin	42	11
Meloxicam	Meloxicam	42	suppressed
Paroxetine Hcl	Paroxetine Hcl	42	15
Buspirone Hcl	Buspirone Hcl	41	11
Pregabalin	Pregabalin	38	suppressed
Bupropion Xl	Bupropion Hcl	37	13
Diclofenac Sodium	Diclofenac Sodium	37	16
Oxycodone Hcl	Oxycodone Hcl	36	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Warfarin Sodium	Warfarin Sodium	36	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	35	23
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	30
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	suppressed
Methimazole	Methimazole	34	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Valsartan	Valsartan	32	suppressed
Donepezil Hcl	Donepezil Hcl	31	11
Glimepiride	Glimepiride	31	13
Glipizide	Glipizide	30	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Lorazepam	Lorazepam	30	suppressed
Azelastine Hcl	Azelastine Hcl	29	suppressed
Ketoconazole	Ketoconazole	29	15
Meclizine Hcl	Meclizine Hcl	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Ammonium Lactate	Ammonium Lactate	26	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	25	suppressed
Latanoprost	Latanoprost	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Colchicine	Colchicine	24	11
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	12
Lovastatin	Lovastatin	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Ibuprofen	Ibuprofen	22	11
Ondansetron Hcl	Ondansetron Hcl	22	suppressed
Incruse Ellipta	Umeclidinium Bromide	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	suppressed
Klor-Con M20	Potassium Chloride	20	suppressed
Trospium Chloride	Trospium Chloride	20	suppressed
Calcitriol	Calcitriol	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	11
Valacyclovir	Valacyclovir Hcl	19	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Labetalol Hcl	Labetalol Hcl	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Topiramate	Topiramate	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	13
Azithromycin	Azithromycin	15	14
Baclofen	Baclofen	15	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	15	suppressed
Cephalexin	Cephalexin	14	12
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	14	14
Ondansetron Odt	Ondansetron	14	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	13	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Primidone	Primidone	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Dulera	Mometasone/Formoterol	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Naproxen	Naproxen	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Nystop	Nystatin	12	suppressed
Peg-3350 And Electrolytes	Peg3350/Sod Sulf,bicarb,cl/Kcl	12	11
Prednisone	Prednisone	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Risperidone	Risperidone	11	suppressed
Trueplus Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error